Related Experiment Video

Updated: Jun 17, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Maintenance therapy in acute myeloid leukemia revisited: will new agents rekindle an old interest?

Utz Krug1, Michael Lübbert, Thomas Büchner

  • 1Department of Medicine, Hematology/Oncology, University of Münster, Münster, Germany.

Current Opinion in Hematology
|January 12, 2010
PubMed
Abstract

Insights

New targeted therapies show promise for acute myeloid leukemia (AML) treatment beyond traditional chemotherapy. Demethylating drugs, in particular, may offer prolonged maintenance therapy due to their unique anti-leukemic mechanisms.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Established cytotoxic chemotherapy for acute myeloid leukemia (AML) has limitations.
  • Recent large-scale clinical trials highlight the need for alternative treatment strategies.

Purpose of the Study:

  • To assess the potential and limitations of current AML treatments.
  • To explore alternative approaches for improving AML therapy.

Main Methods:

  • Review of recent large-scale clinical trials.
  • Analysis of early results from novel targeted agents.

Main Results:

  • Early data from targeted agents, including demethylating drugs, tyrosine kinase inhibitors, farnesylation inhibitors, and angiogenesis inhibitors, are emerging.
  • These agents show potential for being less toxic than traditional chemotherapy.

Conclusions:

  • Novel agents, especially demethylating drugs, demonstrate potential for prolonged maintenance treatment in AML.
  • The delayed antileukemic mechanism of demethylating drugs supports their role in long-term AML management.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications